TMCnet - World's Largest Communications and Technology Community



RNN, CHYR, ZLCS, UAL, CATM, CLWR Are Seasonally Ripe To Go Down In the Next Five Weeks
[February 12, 2013]

RNN, CHYR, ZLCS, UAL, CATM, CLWR Are Seasonally Ripe To Go Down In the Next Five Weeks

Feb 12, 2013 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / is monitoring the Seasonality of Rexahn Pharmaceuticals Inc (AMEX:RNN), Chyron Corp (NASDAQ:CHYR), Zalicus Inc (NASDAQ:ZLCS), United Continental Holdings Inc (NYSE:UAL), CARDTRONICS INC. (NASDAQ:CATM), Clearwire Corp (NASDAQ:CLWR) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: The following stocks are expected to go Down: Symbol Company Expected Return Odds By The Following Date RNN Rexahn Pharmaceuticals Inc -9.59% 100.00% (7 of 7) Wednesday, February 20th 2013 CHYR Chyron Corp -9.76% 92.31% (12 of 13) Monday, March 4th 2013 ZLCS Zalicus Inc -11.41% 100.00% (7 of 7) Friday, March 15th 2013 UAL United Continental Holdings Inc -8.71% 85.71% (6 of 7) Wednesday, February 20th 2013 CATM CARDTRONICS INC. -6.24% 100.00% (5 of 5) Wednesday, February 27th 2013 CLWR Clearwire Corp -7.47% 100.00% (5 of 5) Monday, February 25th 2013 Rexahn Pharmaceuticals Inc (AMEX:RNN) - Rexahn Pharmaceuticals, Inc., a development stage biopharmaceutical company, engages in the discovery and development of treatments for cancer and other disorders of central nervous system. The company s product candidates include Archexin that is in Phase II clinical trials for the treatment of renal cell carcinoma, glioblastoma, ovarian cancer, stomach cancer, and pancreatic cancer; Serdaxin, which has completed Phase IIb clinical trial for the treatment of depression and Parkinson s disease; and Zoraxel that has completed Phase IIa clinical trials for the treatment of for sexual dysfunction through modulating the sexual activity control center in the brain. Its pre-clinical product pipeline comprises RX-1792, a small molecule anticancer epidermal growth factor receptor inhibitor; RX-5902, small molecule anticancer RNA helicase regulator; RX-3117, a small molecule anticancer DNA synthesis inhibitor to treat cancer cells; RX-8243, a small molecule anticancer aurora kinase inhibitor; RX-0201-Nano, a nanoliposomal anticancer Akt inhibitor; RX-0047-Nano, a nanoliposomal anticancer HIF-1 alpha inhibitor; and RX-21101, a nanopolymer anticancer drug. The company has various collaborative research and development relationships with universities, research institutions, and other organizations, including Teva Pharmaceutical Industries; TheraTarget, Inc.; Korea Research Institute of Chemical Technology; The University of Maryland Baltimore; Revaax Pharmaceuticals LLC; and Rexgene Biotech Co., Ltd. Rexahn Pharmaceuticals, Inc. was founded in 2001 and is based in Rockville, Maryland..

Chyron Corp (NASDAQ:CHYR) - Chyron Corporation develops, manufactures, markets, and supports hardware and software products that are designed to provide broadcast-quality graphics and audio for live and pre-recorded productions and to enhance workflow and video asset management for broadcast operations. Its graphics solutions include the Axis World Graphics (Axis) online content creation software and order management system, on-air graphics systems, clip servers, channel branding, and graphics asset management solutions. The company s graphics products provide broadcast-quality, real-time, HD/SD, 2D/3D, graphics creation and playout for television stations, networks, video production, and post-production markets. Its hardware products include HyperX3.1, LEX3.1, and MicroX3, which are 2D/3D graphics platforms and systems that integrate a Windows front end with real-time video processing; Channel Box systems that features 2D/3D design and playout for branding applications; and XClyps, XClyps SAN, and MicroClyps systems for providing quality and control over graphics playout. The company also provides Axis World Graphics, cloud-based graphics creation system, designed specifically for broadcasters; and Axis order management systems to the specifications of a select group of its high-profile clients. In addition, it offers software products, such as Lyric, an advanced graphics creation and playback application; and Lyric PRO for graphics creation and real-time live playout application. Further, it provides newsroom integration and graphics/video asset management products; BlueNet, an end-to-end workflow solution; and graphic design, technical, and support and training services. The company was formerly known as The Computer Exchange, Inc. and changed its name to Chyron Corporation in November 1975. Chyron Corporation was founded in 1966 and is headquartered in Melville, New York..

Zalicus Inc (NASDAQ:ZLCS) - Zalicus Inc., a biopharmaceutical company, discovers and develops drug candidates focusing on the treatment of pain and inflammation. The company s clinical and preclinical product candidates include Synavive, a glucocorticoid prednisolone product candidate, which is in Phase IIb clinical trial for the treatment of rheumatoid arthritis; Z160, an N-type calcium channel blocker that has completed Phase I clinical trial to treat neuropathic and inflammatory pain; and Z944, an oral T-type calcium channel blocker, which is in Phase I clinical trial for the treatment of various chronic pain conditions, as well as sodium channels to treat acute and chronic inflammatory, and neuropathic pain. It has research collaboration agreement with Hydra Biosciences, Mallinckrodt Inc., and Amgen Inc.; research and license agreement with Fovea Pharmaceuticals SA and Novartis; and cooperative research and development agreement with the United States Army Medical Research Institute for Infectious Diseases. The company was formerly known as CombinatoRx, Incorporated and changed its name to Zalicus Inc. in September 2010. Zalicus Inc. was founded in 2000 and is based in Cambridge, Massachusetts..

United Continental Holdings Inc (NYSE:UAL) - United Continental Holdings, Inc., through its subsidiaries, engages in the provision of passenger and cargo air transportation services. As of July 12, 2012, it operated approximately 5,605 flights a day to 375 airports on 6 continents from its hubs in Chicago, Cleveland, Denver, Guam, Houston, Los Angeles, New York/Newark, San Francisco, Tokyo, and Washington, D.C. The company was formerly known as UAL Corporation and changed its name to United Continental Holdings, Inc. in October 2010. United Continental Holdings, Inc. was founded in 1934 and is headquartered in Chicago, Illinois..

CARDTRONICS INC. (NASDAQ:CATM) - Cardtronics, Inc., together with its subsidiaries, provides automated consumer financial services through its network of automated teller machines (ATMs) and multi-function financial services kiosks. As of December 31, 2011, it offered services to approximately 52,900 devices across its portfolio, which included approximately 46,000 devices located in 50 states of the United States, as well as in the U.S. territories of Puerto Rico and the U.S. Virgin Islands; approximately 3,500 devices throughout the United Kingdom; approximately 2,800 devices throughout Mexico; and approximately 600 devices in Canada. The company also deployed approximately 2,200 multi-function financial services kiosks in the United States. Its ATMs and financial services kiosks offer cash dispensing and bank account balance inquiry services, as well as other consumer financial services, including bill payments, check cashing, remote deposit capture, and money transfer services. In addition, the company provides various forms of managed service solution, including monitoring, maintenance, cash management, customer service, and transaction processing services. Further, it partners with national financial institutions to brand its ATMs and financial services kiosks with their logos. As of December 31, 2011, the company had approximately 15,400 company-owned ATMs under contract with financial institutions to place their logos on those machines. Additionally, it provides financial institutions with surcharge-free program through its Allpoint network, as well as owns and operates an electronic funds transfer transaction processing platform that provides transaction processing services to its network of ATMs and financial services kiosks, and ATMs owned and operated by third parties. The company was formerly known as Cardtronics Group, Inc. and changed its name to Cardtronics, Inc. in January 2004. Cardtronics, Inc. was founded in 1989 and is headquartered in Houston, Texas..

Clearwire Corp (NASDAQ:CLWR) - Clearwire Corporation, through its subsidiaries, provides fourth generation wireless broadband services in the United States. The company builds and operates mobile broadband networks that offer high-speed mobile Internet and residential Internet access services. It serves retail customers through its CLEAR brand. The company markets its products and services directly to consumers, as well as through cellular retailers, consumer electronics stores, satellite television dealers, and computer sales and repair stores; and through company-operated retail outlets. As of October 25, 2012, it had 1.4 million retail subscribers and 9.1 million wholesale subscribers. As of October 2012, Clearwire Corporation operates as s subsidiary of Sprint Nextel Corp.. has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO +1-800-715-9999 SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Thomas Ronk ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy